Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-5565 Clinical Pharmacology Study in Japanese Subjects With Varying Renal Function
jRCT2080222129Phase 1Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of mirogabalin in chronic kidney disease (CKD) and end-stage kidney disease (ESKD) (5 arms), sponsored by Daiichi Sankyo Co., Ltd. Started Jun 2013; status: completed.
02
Drugs
mirogabalin
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on jRCT2080222129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222129.